KORU Medical Systems KRMD Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 61.9%-1.6pp | 62.3%-1.1pp | 62.3%-0.5pp | 63.2%+0.7pp | 63.5%+3.2pp | |
| Operating margin | -6%+10.3pp | -7.2%+11.9pp | -10.3%+11.8pp | -13.2%+10.0pp | -16.3%+15.0pp | |
| Net margin | -5.3%+9.8pp | -6.4%+11.6pp | -9.5%+27.9pp | -12.3%+25.9pp | -15.1%+30.1pp | |
| Returns | ||||||
| Return on equity | -13.7%+16.2pp | -15.6%+17.1pp | -21.7%+31.3pp | -25.6%+24.6pp | -29.9%+24.4pp | |
| Return on invested capital | -22.7%+25.8pp | -26%+27.3pp | -33.1%+8.6pp | -40%+3.2pp | -48.5%+4.7pp | |
| Efficiency | ||||||
| Asset turnover | 1.6×+0.3× | 1.5×+0.3× | 1.4×+0.4× | 1.4×+0.4× | 1.3×+0.4× | |
| Liquidity | ||||||
| Current ratio | 2.3×-0.1× | 2.4×-0.2× | 2.5×-0.5× | 2.9×-0.9× | 2.4×-1.6× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | |
| Per Share | ||||||
| Book value per share | $0.37+2.7% | $0.37+0.5% | $0.36-7.9% | $0.36-12.4% | $0.36-15.0% | |
| Valuation | ||||||
| Market capitalization | $206.24M+24.9% | $269.13M+52.5% | $177.08M+41.6% | $164.26M+35.6% | $116.73M+8.2% | |
| Price / sales | 4.8×+0.3× | 6.5×+1.3× | 4.5×+0.6× | 4.5×+0.5× | 3.3×-0.4× | |
| Price / book | 12.2×+2.2× | 15.8×+5.3× | 10.8×+3.7× | 9.9×+3.5× | 7.1×+1.5× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are KORU Medical Systems's profit margins?
- KORU Medical Systems (KRMD) runs a 61.9% gross margin and a -6.0% operating margin, with a -5.3% net margin.
- Where do KORU Medical Systems's ratios come from?
- Every ratio is computed from KORU Medical Systems's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
